Canephron relieves the symptoms and helps reduce the occurrence of UTIs and medically diagnosed cystitis, and supports urinary tract health and function. 

The anti-inflammatory [4], analgesic [5], anti-spasmodic [6], and bacterial flushing [7] effects relieve all the major symptoms of localised UTIs in a comparable manner to that of antibiotics [8].

Canephron is endorsed and recommended as a first line, antibiotic sparing treatment for UTIs/cystitis in the European Association of Urology Guidelines [10], and this Guideline is endorsed and adopted [11] by the Urology Society of Australia and New Zealand in the treatment of UTIs/cystitis.

One pack contains 30 coated tablets.